Molecular basis of Cromer blood group antigens
- 1 February 2000
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 40 (2) , 208-213
- https://doi.org/10.1046/j.1537-2995.2000.40020208.x
Abstract
BACKGROUND: The Cromer blood group system consists of 10 antigens located on decay‐accelerating factor (DAF). Previous molecular genetic analysis has determined the basis for four of these antigens. The present study was undertaken to identify the mutations that determine the remaining antigens. STUDY DESIGN AND METHOD: Existing or new data were used to localize each Cromer system antigen to a specific short consensus repeat (SCR) domain of DAF. The exon encoding that SCR domain was amplified by using the polymerase chain reaction (PCR) on genomic DNA obtained from individuals of that Cromer phenotype, and the DNA product was subjected to DNA sequence analysis. RESULTS: The Tca/Tcc polymorphism is due to an R18P amino acid substitution in SCR1 of DAF. The Es(a+)/Es(a–) polymorphism is due to an I46N mutation in SCR1 of DAF. The WESb/WESa polymorphism is due to an L48R mutation in SCR1 of DAF. The UMC+/UMC– polymorphism is due to a T216M substitution in SCR4 of DAF. CONCLUSIONS: With information from previous reports and the findings of this study, the molecular genetic basis of all known alleles of the Cromer blood group system has been elucidated. Single amino acid substitutions are responsible for 9 of the 10 antigens (all except the multiple‐epitope antigen IFC).Keywords
This publication has 24 references indexed in Scilit:
- Location of WESb on decay‐accelerating factorTransfusion, 1995
- Use of the MAIEA Technique to Confirm the Relationship between the Cromer Antigens and Decay‐Accelerating Factor and to Assign Provisionally Antigens to the Short‐Consensus RepeatsVox Sanguinis, 1993
- Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.Journal of Clinical Investigation, 1991
- Adsorption of anti‐Cra by human platelet concentratesTransfusion, 1991
- Cromer‐Related Antigens – Blood Group Determinants on Decay‐Accelerating FactorVox Sanguinis, 1989
- Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for dafThe Journal of Experimental Medicine, 1988
- A clinically significant anti‐CraTransfusion, 1988
- Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsNature, 1987
- Tca: a high‐frequency blood group antigenTransfusion, 1983
- Another example of anti‐TcaTransfusion, 1981